Data Resource Profile: The French National Uniform Hospital Discharge Data Set Database (PMSI).
暂无分享,去创建一个
[1] W. Edwards,et al. Valvular heart disease associated with fenfluramine-phentermine. , 1997, The New England journal of medicine.
[2] M. Humbert,et al. Fenfluramine-like cardiovascular side-effects of benfluorex , 2009, European Respiratory Journal.
[3] L. Remontet,et al. A Suitable Approach to Estimate Cancer Incidence in Area without Cancer Registry , 2011, Journal of cancer epidemiology.
[4] B. Michel,et al. Évaluation des pratiques de prescription relatives à 6 médicaments facturés en sus des GHS en Alsace , 2012 .
[5] G. Chatellier,et al. [Role of French hospital claims databases from care units in epidemiological studies: the example of the "Cohorte Enfant Scanner" study]. , 2012, Revue d'epidemiologie et de sante publique.
[6] Anke Neumann,et al. Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus , 2010, Pharmacoepidemiology and drug safety.
[7] A. Schott,et al. Is it possible to estimate the incidence of breast cancer from medico-administrative databases? , 2008, European Journal of Epidemiology.
[8] J. Timsit,et al. Reliability of diagnostic coding in intensive care patients , 2008, Critical care.
[9] L. Cannistra,et al. Regression of multivalvular regurgitation after the cessation of fenfluramine and phentermine treatment. , 1998, The New England journal of medicine.
[10] F. Alla,et al. Comparison of the Short-Term Risk of Bleeding and Arterial Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Newly Treated With Dabigatran or Rivaroxaban Versus Vitamin K Antagonists , 2015, Circulation.
[11] Marc Humbert,et al. Benfluorex and Unexplained Valvular Heart Disease: A Case-Control Study , 2010, PloS one.
[12] Maryse Lapeyre-Mestre,et al. Use of multiple sources and capture–recapture method to estimate the frequency of hospitalizations related to drug abuse , 2012, Pharmacoepidemiology and drug safety.
[13] Catherine Quantin,et al. CHAÎNAGE DE BASES DE DONNÉES ANONYMISÉES POUR LES ÉTUDES ÉPIDÉMIOLOGIQUES MULTICENTRIQUES NATIONALES ET INTERNATIONALES : PROPOSITION D'UN ALGORITHME CRYPTOGRAPHIQUE , 2009 .
[14] C. Couchoud,et al. Intérêt de l'utilisation du PMSI pour l'analyse d'activité cancérologique d'une structure de soins multidisciplinaire : l'expérience de la coordination de cancérologie des Hospices Civils de Lyon , 2002 .
[15] N. Bossard,et al. Analyse critique des données du PMSI pour l’épidémiologie des cancers : une approche longitudinale devient possible , 2011 .
[16] Catherine Quantin,et al. Linking anonymous databases for national and international multicenter epidemiological studies: A cryptographic algorithm , 2009 .
[17] I. Baldi,et al. Évaluation des performances du PMSI pour l’identification des tumeurs incidentes du système nerveux central par rapport à un registre spécialisé en Gironde, France, en 2004 , 2012 .
[18] J. Fauconnier,et al. [Relationship between in-hospital mortality rate and patient volume for total hip arthroplasty in the Rhône-Alpes public hospitals]. , 2001, Revue d'épidémiologie et de santé publique.
[19] T. Cloward,et al. Endocardial fibrosis associated with fenfluramine-phentermine. , 1998, New England Journal of Medicine.
[20] J. Epinette,et al. Cost-effectiveness model comparing dual-mobility to fixed-bearing designs for total hip replacement in France. , 2016, Orthopaedics & traumatology, surgery & research : OTSR.
[21] J. Bonnetblanc,et al. Syndrome d’hypersensibilité médicamenteuse en pratique interniste : pièges diagnostique et thérapeutique.Huit observations , 2000 .
[22] Paul Landais,et al. Outcomes After Hip Fracture Surgery Compared With Elective Total Hip Replacement. , 2015, JAMA.
[23] C. Colin,et al. Qualité et utilité d'un identifiant patient anonyme et unique pour le chaînage des séjours hospitaliers dans les bases de données médicoéconomiques françaises , 2007 .
[24] A. Schott,et al. Breast cancer incidence using administrative data: correction with sensitivity and specificity. , 2009, Journal of clinical epidemiology.